APOTEX-ZOLEDRONIC (Apotex Pty Ltd)
Product name
APOTEX-ZOLEDRONIC
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
177 (255 working days)
Active ingredients
Zoledronic acid monohydrate
Registration type
EOI
Indication
As an adjunct to adjuvant treatment for women with early breast cancer who are in established menopause.